University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > John Y. M. Koo

John Y. M. Koo, M.D.

Director, Psoriasis, Phototherapy and Skin Treatment Clinic

Dr. John Koo is the director of the Psoriasis, Phototherapy and Skin Treatment Clinic. His main interest is in psoriasis therapy, phototherapy, eczema psychodermatology and quality of life research. He is on the editorial board for the Journal of the American Academy of Dermatology.

Clinics

Psoriasis, Phototherapy and Skin Treatment Clinic
515 Spruce St.
San Francisco, CA 94118
Phone: (415) 476–4701
Fax: (415) 502–4126

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Conditions & Treatments

More about John Y. M. Koo

Additional Languages

Japanese

Education

Harvard University School of Medicine 1981

Residencies

UCLA Medical Center, Psychiatry 1985
UCSF Medical Center, Dermatology 1988

Selected Research and Publications

  1. Asztalos ML, Heller MM, Lee ES, Koo J. The impact of emollients on phototherapy: A review. J Am Acad Dermatol. 2013 May; 68(5):817-24.
  2. Ladizinski B, Heller MM, Bhutani T, Zitelli KB, Koo JY. Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy. J Drugs Dermatol. 2013 Feb 1; 12(2):e20-4.
  3. Park KK, Koo J. Use of psychotropic drugs in dermatology: Unique perspectives of a dermatologist and a psychiatrist. Clin Dermatol. 2013 Jan; 31(1):92-100.
  4. Wong JW, Koo JY. Delusions of parasitosis. Indian J Dermatol. 2013 Jan; 58(1):49-52.
  5. Wong JW, Nguyen TV, Koo JY. Primary psychiatric conditions: dermatitis artefacta, trichotillomania and neurotic excoriations. Indian J Dermatol. 2013 Jan; 58(1):44-8.
  6. Mutgi K, Koo J. Update on the role of systemic vitamin d in atopic dermatitis. Pediatr Dermatol. 2013 May; 30(3):303-7.
  7. Kamangar F, Neuhaus IM, Koo JY. An evidence-based review of skin cancer rates on biologic therapies. J Dermatolog Treat. 2012 Aug; 23(4):305-15.
  8. Wong JW, Nguyen TV, Bhutani T, Koo JY. Treatment of psoriasis and long-term maintenance using 308 nm excimer laser, clobetasol spray, and calcitriol ointment: a case series. J Drugs Dermatol. 2012 Aug; 11(8):994-6.
  9. Wong JW, Davis SA, Feldman SR, Koo JY. Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol. 2012 Aug; 11(8):957-62.
  10. Wong JW, Koo JY. The safety of systemic treatments that can be used for geriatric psoriasis patients: a review. Dermatol Res Pract. 2012; 2012:367475.
  11. Wong JW, Kamangar F, Nguyen TV, Koo JY. Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm. Skin Therapy Lett. 2012 May; 17(5):6-9.
  12. Heller MM, Wong JW, Nguyen TV, Lee ES, Bhutani T, Menter A, Koo JY. Quality-of-life instruments: evaluation of the impact of psoriasis on patients. Dermatol Clin. 2012 Apr; 30(2):281-91, ix.
  13. Moscaliuc ML, Heller MM, Lee ES, Koo J. Goeckerman therapy: a very effective, yet often forgotten treatment for severe generalized psoriasis. J Dermatolog Treat. 2013 Feb; 24(1):34-7.
  14. Lee ES, Heller MM, Kamangar F, Park KK, Koo JY. Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study. J Drugs Dermatol. 2012 Mar; 11(3):413-4.
  15. Park KK, Murase JE, Koo J. Long-term prognosis of vitiligo patients on narrowband UVB phototherapy. J Am Acad Dermatol. 2012 Feb; 66(2):326-7.
  16. Keaney TC, Bhutani T, Sivanesan P, Bandow GD, Weinstein SB, Cheung LC, Malick F, Koo J. Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis. J Am Acad Dermatol. 2012 Oct; 67(4):636-41.
  17. Bhutani T, Koo J. A review of the chemopreventative effects of oral retinoids for internal neoplasms. J Drugs Dermatol. 2011 Nov; 10(11):1292-8.
  18. Kannan S, Heller MM, Lee ES, Koo JY. The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know. J Dermatolog Treat. 2013 Apr; 24(2):148-52.
  19. Muellenhoff MW, Koo JY. Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. J Dermatolog Treat. 2012 Aug; 23(4):290-304.
  20. Patel T, Bhutani T, Busse KL, Koo J. Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial. Cutis. 2011 Sep; 88(3):149-54.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California